Published in Mol Cell on August 01, 2000
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics (2012) 2.08
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J Med Genet (2004) 1.85
The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma. Pigment Cell Melanoma Res (2009) 1.62
Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci U S A (2008) 1.62
A role for IRF4 in the development of CLL. Blood (2013) 1.54
Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol Histopathol (2005) 1.47
TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas. Blood (2012) 1.47
DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J (2005) 1.44
Interplay between HIV-1 infection and host microRNAs. Nucleic Acids Res (2011) 1.36
Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A (2002) 1.26
Molecular basis of CLL. Semin Cancer Biol (2010) 1.26
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia. Blood (2009) 1.20
Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Mol Cell Biol (2002) 1.20
TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc Natl Acad Sci U S A (2002) 1.19
Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J Clin Invest (2014) 1.16
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression. Breast Cancer Res (2012) 1.13
Technological overview of iPS induction from human adult somatic cells. Curr Gene Ther (2013) 1.13
Solution structure and backbone dynamics of the pleckstrin homology domain of the human protein kinase B (PKB/Akt). Interaction with inositol phosphates. J Biomol NMR (2004) 1.06
ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice. Proc Natl Acad Sci U S A (2013) 1.05
Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). Proc Natl Acad Sci U S A (2012) 1.04
PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J Cell Biol (2004) 1.03
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood (2011) 1.02
Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings. Proc Natl Acad Sci U S A (2005) 0.99
High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood (2007) 0.98
BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation. Sci Signal (2013) 0.97
Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies. Blood (2011) 0.96
New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies. Clin Cancer Res (2010) 0.94
TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. Proc Natl Acad Sci U S A (2007) 0.94
Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain. Curr Med Chem (2011) 0.93
T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Proc Natl Acad Sci U S A (2003) 0.92
Identification, characterization and metagenome analysis of oocyte-specific genes organized in clusters in the mouse genome. BMC Genomics (2005) 0.92
Maternal effect genes: Findings and effects on mouse embryo development. Clin Exp Reprod Med (2014) 0.90
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia. Leuk Res (2007) 0.88
Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4. J Biol Chem (2013) 0.88
Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat Genet (2016) 0.87
Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation. Blood (2006) 0.86
Therapeutic Implications of Targeting AKT Signaling in Melanoma. Enzyme Res (2011) 0.85
Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics. Int J Mol Sci (2013) 0.84
Current status of human chromosome 14. J Med Genet (2002) 0.84
Interaction between TCL1 and Epac1 in the activation of Akt kinases in plasma membranes and nuclei of 8-CPT-2-O-Me-cAMP-stimulated macrophages. Cell Signal (2007) 0.82
EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells. J Virol (2006) 0.81
Lysosomal interaction of Akt with Phafin2: a critical step in the induction of autophagy. PLoS One (2014) 0.81
MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematol (2013) 0.80
The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB. PLoS One (2009) 0.80
miR deregulation in CLL. Adv Exp Med Biol (2013) 0.79
The Role of miRNA in Haematological Malignancy. Bone Marrow Res (2013) 0.79
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. Leukemia (2013) 0.78
Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1. Br J Cancer (2003) 0.78
Akt mediated phosphorylation of LARP6; critical step in biosynthesis of type I collagen. Sci Rep (2016) 0.78
Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival. Oncotarget (2015) 0.78
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia. Cell Death Dis (2016) 0.78
Inherited predisposition to chronic lymphocytic leukemia. Expert Rev Hematol (2008) 0.78
Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo. Oncogenesis (2013) 0.76
Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas. Blood (2012) 0.76
TCL1 expression patterns in Waldenström macroglobulinemia. Mod Pathol (2015) 0.76
The long journey of TCL1 transgenic mice: lessons learned in the last 15 years. Gene Expr (2015) 0.76
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. Leukemia (2015) 0.75
Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility. Nat Genet (2017) 0.75
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development? Front Oncol (2016) 0.75
A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation. Stem Cell Reports (2017) 0.75
Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2014) 0.75
GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons. BMC Neurosci (2010) 0.75
Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures. Mol Cell Proteomics (2017) 0.75
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. Virchows Arch (2012) 0.75
1H, 15N and 13C chemical shift assignments of the Pleckstrin Homology domain of the Human Protein Kinase B (PKB/Akt). J Biomol NMR (2003) 0.75
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity (1995) 7.08
A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol (2001) 6.50
Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science (1993) 4.63
Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res (1989) 4.34
Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1994) 3.46
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
Two community outbreaks of human infection with Yersinia enterocolitica. J Hyg (Lond) (1973) 2.97
Anomalous systemic arterial supply to normal basal segments of the left lower lobe. Ann Thorac Surg (1999) 2.61
A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int (1994) 2.42
Cloning and sequence analysis of cDNA for the luminescent protein aequorin. Proc Natl Acad Sci U S A (1985) 2.42
Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology (1996) 2.27
A novel phosphodiesterase from cultured tobacco cells. Biochemistry (1976) 1.90
Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain. J Biol Chem (1997) 1.86
The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med (1997) 1.79
Surgically curable "early" adenocarcinoma in the periphery of the lung. Am J Surg Pathol (1994) 1.67
Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet (1997) 1.67
E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res (1996) 1.62
Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res (1997) 1.60
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer (1987) 1.60
Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci (2000) 1.59
The paternal methylation imprint of the mouse H19 locus is acquired in the gonocyte stage during foetal testis development. Genes Cells (2000) 1.56
In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol (1997) 1.53
Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med (1993) 1.52
Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res (1995) 1.51
Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet (1994) 1.50
Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer (1990) 1.46
Degeneration of patellar cartilage in patients with recurrent patellar dislocation following conservative treatment: evaluation with delayed gadolinium-enhanced magnetic resonance imaging of cartilage. Osteoarthritis Cartilage (2009) 1.45
Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment. BJU Int (2003) 1.45
p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer (1993) 1.44
Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res (1992) 1.44
Columnar cell carcinoma of the thyroid gland: a case report and review of the literature. Hum Pathol (1994) 1.44
MR imaging of Pellegrini-Stieda disease. Radiat Med (2000) 1.44
GC/MS analysis of urinary excretion of 9alpha,11beta-PGF2 in acute and exercise-induced asthma in children. Clin Exp Allergy (1998) 1.42
Nonlinear temporal dynamics of the cerebral blood flow response. Hum Brain Mapp (2001) 1.42
Venous malformation of the vulva. BJOG (2001) 1.39
Analysis of loss of heterozygosity in small adenocarcinomas of the lung. Jpn J Clin Oncol (1998) 1.38
Encircling method of trigeminal nerve decompression for neuralgia caused by tortuous vertebrobasilar artery: technical note. Surg Neurol (1995) 1.38
Malignant pleural mesothelioma producing human chorionic gonadotropin. Report of two cases. Am J Surg Pathol (1992) 1.38
Loss of genes on the short arm of chromosome 11 in human lung carcinomas. Jpn J Cancer Res (1987) 1.37
Baculovirus-mediated expression and characterization of the full-length murine DNA methyltransferase. Nucleic Acids Res (1997) 1.35
Comparison of the LMA-ProSeal and LMA-Classic in children. Br J Anaesth (2004) 1.35
A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice. J Natl Cancer Inst (1985) 1.30
The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. Immunol Rev (1994) 1.30
Crystal structure of rat heme oxygenase-1 in complex with heme. FEBS Lett (2000) 1.25
Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem Biophys Res Commun (1997) 1.25
Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Oncogene (2012) 1.25
A mechanism of lithium storage in disordered carbons. Science (1994) 1.24
The cervical aortic arch with aneurysm formation. J Comput Assist Tomogr (1999) 1.20
Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res (1989) 1.20
Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report. Cancer (1989) 1.19
Node dissection in gastric cancer. Br J Surg (1987) 1.19
Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression. Proc Natl Acad Sci U S A (1993) 1.18
DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer (2002) 1.17
Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study. Hum Pathol (1990) 1.16
The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med (1996) 1.16
Molecular cloning of CWP1: a gene encoding a Saccharomyces cerevisiae cell wall protein solubilized with Rarobacter faecitabidus protease I. J Biochem (1995) 1.15
Molecular structure of Rarobacter faecitabidus protease I. A yeast-lytic serine protease having mannose-binding activity. J Biol Chem (1992) 1.14
Papillary carcinoma of the thyroid gland with fibromatosis-like stroma: a case report and review of the literature. Mod Pathol (1995) 1.14
Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol (2001) 1.13
The reaction of cytochrome oxidase with cyanide. Preparation of the rapidly reacting form and its conversion to the slowly reacting form. J Biol Chem (1987) 1.12
Radon Anomaly: A Possible Precursor of the 1978 Izu-Oshima-kinkai Earthquake. Science (1980) 1.11
Clinicopathologic characteristics of adenosquamous carcinoma of the lung. Cancer (1991) 1.11
Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1-mediated hepatic apoptosis. J Exp Med (2000) 1.11
Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res (1999) 1.11
Late bone metastasis from an encapsulated follicular carcinoma of the thyroid without capsular and vascular invasion. Pathol Int (1996) 1.11
A case of intravascular papillary endothelial hyperplasia (Masson's tumor) arising from renal sinus. Jpn J Clin Oncol (1997) 1.10
Uterine deformity caused by surgery during pregnancy. J Comput Assist Tomogr (1994) 1.10
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology (2005) 1.10
The 100-kda U5 snRNP protein (hPrp28p) contacts the 5' splice site through its ATPase site. RNA (2001) 1.09
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion. BJU Int (2004) 1.09
Diffuse follicular variant of papillary carcinoma of the thyroid. Histopathology (1995) 1.09
High density culture of immortalized liver endothelial cells in the radial-flow bioreactor in the development of an artificial liver. Int J Artif Organs (1998) 1.08
Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation. Diabetologia (2012) 1.08
Mating-type genes from asexual phytopathogenic ascomycetes Fusarium oxysporum and Alternaria alternata. Mol Plant Microbe Interact (2000) 1.08
Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion. Diabetologia (2006) 1.07
Role of sequences within the first intron in the regulation of expression of eukaryotic initiation factor 2 alpha. J Biol Chem (1992) 1.07
The Leu-1 B-cell subpopulation in patients with rheumatoid arthritis. J Clin Immunol (1987) 1.06
Spontaneous shunt between the superior mesenteric vein and the right renal vein caused by portal hypertension. J Urol (2001) 1.06
Purification and properties of biliverdin reductases from pig spleen and rat liver. J Biochem (1979) 1.05
Primary mucoepidermoid carcinoma in the thyroid gland. A case report including an ultrastructural and biochemical study. Cancer (1984) 1.05
Structural and phylogenetic analysis of the MHC class I-like Fc receptor gene. J Immunol (1995) 1.05
Multiple sclerosing hemangiomas of the lung. Am J Surg Pathol (1986) 1.04
Binding characteristics of dialkyl phthalates for the estrogen receptor. Biochem Biophys Res Commun (1999) 1.04
Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID). Adv Exp Med Biol (1994) 1.03
Preoperative laser photodynamic therapy in combination with operation in lung cancer. J Thorac Cardiovasc Surg (1985) 1.03
[Studies on the preparation and evaluation of kijitsu, the immature citrus fruits. I. Evaluation of the new drying method]. Yakugaku Zasshi (1988) 1.02
Generation of mutant mice with large chromosomal deletion by use of irradiated ES cells--analysis of large deletion around hprt locus of ES cell. Mamm Genome (1998) 1.02
Two-qubit gate of combined single-spin rotation and interdot spin exchange in a double quantum dot. Phys Rev Lett (2011) 1.01
Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. J Clin Invest (1995) 1.01
Gastrointestinal bleeding following head injury: a clinical study of 433 cases. J Trauma (1977) 1.00
Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest (1990) 1.00
Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic. Cancer Res (1995) 1.00
Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors. Brain Res (1983) 1.00
Hemophagocytic syndrome as the primary clinical symptom of Hodgkin's disease. Ann Hematol (2002) 1.00
Antinociceptive mechanism of the aconitine alkaloids mesaconitine and benzoylmesaconine. Planta Med (1994) 0.99
Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Mod Pathol (1990) 0.99
Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med (1996) 0.98
Spontaneously developed aneurysm of the ductus arteriosus in an adult. Ann Vasc Surg (1999) 0.98
Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2. FEBS Lett (1999) 0.98